ES2257288T3 - Derivados antiepilepticos utilizados en el tratamiento de temblor esencial. - Google Patents

Derivados antiepilepticos utilizados en el tratamiento de temblor esencial.

Info

Publication number
ES2257288T3
ES2257288T3 ES00911816T ES00911816T ES2257288T3 ES 2257288 T3 ES2257288 T3 ES 2257288T3 ES 00911816 T ES00911816 T ES 00911816T ES 00911816 T ES00911816 T ES 00911816T ES 2257288 T3 ES2257288 T3 ES 2257288T3
Authority
ES
Spain
Prior art keywords
tremor
formula
topiramate
patient
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00911816T
Other languages
English (en)
Spanish (es)
Inventor
Gregory S. Connor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of ES2257288T3 publication Critical patent/ES2257288T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
ES00911816T 1999-02-17 2000-02-15 Derivados antiepilepticos utilizados en el tratamiento de temblor esencial. Expired - Lifetime ES2257288T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12041399P 1999-02-17 1999-02-17
US120413P 1999-02-17

Publications (1)

Publication Number Publication Date
ES2257288T3 true ES2257288T3 (es) 2006-08-01

Family

ID=22390119

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00911816T Expired - Lifetime ES2257288T3 (es) 1999-02-17 2000-02-15 Derivados antiepilepticos utilizados en el tratamiento de temblor esencial.

Country Status (24)

Country Link
US (1) US6214867B1 (pt)
EP (1) EP1158950B1 (pt)
JP (1) JP2002539088A (pt)
KR (1) KR100664612B1 (pt)
CN (1) CN1433306A (pt)
AR (1) AR035986A1 (pt)
AT (1) ATE316374T1 (pt)
AU (1) AU779823B2 (pt)
BR (1) BR0008791A (pt)
CA (1) CA2362336C (pt)
CZ (1) CZ295096B6 (pt)
DE (1) DE60025705T2 (pt)
DK (1) DK1158950T3 (pt)
ES (1) ES2257288T3 (pt)
HU (1) HUP0202634A3 (pt)
IL (2) IL144943A0 (pt)
MX (1) MXPA01008387A (pt)
MY (1) MY129238A (pt)
NO (1) NO20014026L (pt)
NZ (1) NZ513724A (pt)
TR (1) TR200103126T2 (pt)
TW (1) TWI228413B (pt)
WO (1) WO2000048549A2 (pt)
ZA (1) ZA200107564B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043731A2 (en) * 2000-11-30 2002-06-06 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
NZ531871A (en) * 2001-09-24 2006-09-29 Ortho Mcneil Pharm Inc Anticonvulsant derivatives such as topiramate useful for the treatment of restless limb syndrome and periodic limb movement disorder
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4981867A (en) 1989-12-08 1991-01-01 The Board Of Trustees Of The Leland Stanford Junior University Treatment of tremor using compounds that depress calcium currents in thalamic and other central nervous system neurons
IL103172A (en) * 1991-09-19 1997-01-10 Mcneilab Inc Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol
US5735693A (en) * 1996-03-29 1998-04-07 Multi Lingua Ltd.. Method and device for learning a foreign language
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування

Also Published As

Publication number Publication date
WO2000048549A3 (en) 2002-04-04
WO2000048549A2 (en) 2000-08-24
HUP0202634A2 (hu) 2002-11-28
BR0008791A (pt) 2005-04-05
AU3364800A (en) 2000-09-04
EP1158950A1 (en) 2001-12-05
NO20014026D0 (no) 2001-08-17
MY129238A (en) 2007-03-30
DE60025705T2 (de) 2006-08-24
CA2362336A1 (en) 2000-08-24
TR200103126T2 (tr) 2002-07-22
NZ513724A (en) 2004-01-30
KR100664612B1 (ko) 2007-01-04
KR20010112272A (ko) 2001-12-20
DK1158950T3 (da) 2006-04-24
IL144943A0 (en) 2002-06-30
CZ295096B6 (cs) 2005-05-18
DE60025705D1 (de) 2006-04-13
TWI228413B (en) 2005-03-01
ATE316374T1 (de) 2006-02-15
HUP0202634A3 (en) 2005-02-28
CA2362336C (en) 2005-04-12
IL144943A (en) 2006-08-20
ZA200107564B (en) 2002-12-13
JP2002539088A (ja) 2002-11-19
CZ20013011A3 (cs) 2002-06-12
US6214867B1 (en) 2001-04-10
MXPA01008387A (es) 2003-06-06
CN1433306A (zh) 2003-07-30
EP1158950B1 (en) 2006-01-25
AU779823B2 (en) 2005-02-10
AR035986A1 (es) 2004-08-04
NO20014026L (no) 2001-10-17

Similar Documents

Publication Publication Date Title
ES2228465T3 (es) Uso derivados anticonvulsionantes para el tratamiento de cefaleas en brotes.
US6420369B1 (en) Anticonvulsant derivatives useful in treating dementia
US8084491B2 (en) Treatments for wound healing
CN1298309A (zh) 治疗肛门区疼痛的方法及其组合物
JP2003530300A (ja) 体重低下を維持することに有用な抗痙攣薬誘導体
CA2267945C (en) Anticonvulsant derivatives useful in treating neuropathic pain
ES2257288T3 (es) Derivados antiepilepticos utilizados en el tratamiento de temblor esencial.
JP2005514352A6 (ja) 自己免疫疾患の治療法
JP2005514352A (ja) 自己免疫疾患の治療法
US10849877B2 (en) Reduction of epileptic seizures
ES2211507T3 (es) Uso de derivados anti-convulsivos para tratar la bulimia nerviosa.
JP2002543123A (ja) コカイン依存症の処置において有用な抗痙攣性誘導体
JP2003524623A (ja) 血液グルコースレベルを下げることに有用な抗痙攣薬誘導体
MXPA99003258A (en) Anticonvulsant derivatives useful in treating neuropathic pain